Purchases and Sales Made in Q3 2020 in Kala Pharmaceuticals, Inc. (KALA)
This table provides information about the institutional ownership of Kala Pharmaceuticals, Inc. (KALA) during Q3 2020. The information is specifically focused on institutions that hold shares of Kala Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 16, 2020
Q3 2020
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-105K- 40.06% |
$791K - $1.17M
|
158K
$1.16M
|
|
|
Nov 12, 2020
Q3 2020
|
Barclays PLC
London, X0 |
SELL
|
- |
-131K- 81.99% |
$981K - $1.45M
|
28.7K
$210K
|
|
|
Nov 12, 2020
Q3 2020
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-138K- 73.26% |
$1.03M - $1.53M
|
50.3K
$368K
|
|
|
Nov 16, 2020
Q3 2020
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-147K- 85.28% |
$1.1M - $1.63M
|
25.3K
$185K
|
|
|
Nov 16, 2020
Q3 2020
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-169KClosed |
$1.27M - $1.88M
|
0
$0
|
|
|
Nov 12, 2020
Q3 2020
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-185K- 56.99% |
$1.39M - $2.06M
|
140K
$1.02M
|
|
|
Nov 16, 2020
Q3 2020
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-220K- 88.59% |
$1.65M - $2.44M
|
28.3K
$207K
|
|
|
Nov 13, 2020
Q3 2020
|
Eam Investors, LLC
Solana Beach, CA |
SELL
|
- |
-253KClosed |
$1.9M - $2.81M
|
0
$0
|
|
|
Oct 07, 2020
Q3 2020
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-357KClosed |
$2.68M - $3.96M
|
0
$0
|
|
|
Nov 16, 2020
Q3 2020
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-361KClosed |
$2.71M - $4.01M
|
0
$0
|
|
|
Nov 16, 2020
Q3 2020
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-376KClosed |
$2.82M - $4.18M
|
0
$0
|
|
|
Nov 13, 2020
Q3 2020
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-507KClosed |
$3.8M - $5.63M
|
0
$0
|
|
|
Nov 12, 2020
Q3 2020
|
Banco Bilbao Vizcaya Argentaria, S.A.
|
SELL
|
- |
-798KClosed |
$5.98M - $8.86M
|
0
$0
|